Evidence map›Paper›PMID 41923822›Full record

ArticleJournal of pharmaceutical policy and practice2026

From supply to strategy: leveraging central medical stores experiences and information for health system strengthening.

Maria-Belen Tarrafeta-Sayas, Christophe Rerat, Sophie Pilon, Mieja Vola Rakotonarivo, Louis Dèhoumon Koukpemedji, Serge Yapo, Rachel Duncan, Danielle Hodjo, Landry Stéphane Baki, Aser Minoungou and 1 more

Abstract read
In one paragraph

Article in Journal of pharmaceutical policy and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Maria-Belen Tarrafeta-SayasDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.ORCID https://orcid.org/0009-0002-7396-3222
Christophe ReratHealth Products Division, World Health Organization (WHO), Geneva, Switzerland.
Sophie PilonIndependent Consultant, Noirmoutier-en-l'île, France.
Mieja Vola RakotonarivoCentral Medical Stores for Essential Medicines and Medical Equipment in Madagasar, SALAMA, Centrale d'Achats de Médicaments Essentiels et Materiel Médical de Madagascar, Antananarivo, Madagascar.
Louis Dèhoumon KoukpemedjiBenin Health Products Supply Society, SoBAPS, Société Béninoise pour l'Approvisionnement en Produits de Santé, Cotonou, Benin.
Serge YapoNew Public Health Pharmacy in Cote d'Ivoire, NPSP, Nouvelle Pharmacie de la Santé Publique de Côte d'Ivoire, Abidjan, Côte d'Ivoire.
Rachel DuncanDirectorate of Pharmaceutical Activities, DAP, Direction de l'Activité Pharmaceutique, Ministry of Health, Public Hygiene, and Universal Health Coverage, Abidjan, Côte d'Ivoire.
Danielle HodjoDirectorate of Pharmaceutical Activities, DAP, Direction de l'Activité Pharmaceutique, Ministry of Health, Public Hygiene, and Universal Health Coverage, Abidjan, Côte d'Ivoire.
Landry Stéphane BakiCentral Medical Stores for Essential Generic Medicines and Medical Supplies in Burkina Faso, CAMEG Centrale d'achat des médicaments essentiels génériques et des consommables médicaux, Ouagadougou, Burkina Faso.
Aser MinoungouAfrican Association of Central Medical Stores for Essential Medicines, ACAME, Association des Centrales d'Achats de Médicaments Essentiels, Ouagadougou, Burkina Faso.
Raffaella RavinettoDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.ORCID https://orcid.org/0000-0001-7765-2443

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The availability and affordability of essential medicines and other health products are critical to building resilient health systems and achieving Universal Health Coverage (UHC). In many Francophone African countries, Central Medical Stores (CMS) play a key role in procuring and distributing medicines for the public sector. As such, they generate first-hand data and knowledge on availability, pricing, and the performance of national supply chains. This Comment argues that CMS should be recognised not only as technical providers, but as strategic partners in national pharmaceutical policy and health system governance. Despite their constraints and the challenging environments in which they operate, CMS routinely generate supply-chain data that often remain underused beyond day-to-day operations. Where existing data sources on access to medicines are incomplete or unavailable, CMS data can help fill key gaps and inform planning, monitoring, and policy decisions. To operationalise this shift, we propose strengthening CMS analytical and policy-interface capacity and formalising collaboration and governance mechanisms with Ministries of Health and partners.

Indexed as

accessAfricaEssential medicinespharmaceutical policiespricepublic sectorsupply

Identifiers

PMID41923822
PMCPMC13037131

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.